IN-PROCESS RESEARCH AND DEVELOPMENT AND DEFERRED TAX LIABILITY (Tables)

9 Months Ended

Dec. 31, 2023

In-process Research And Development And Deferred Tax Liability

Schedule of in-process research and development

		Value as of
Project #	Description	December 31, 2023		March 31, 2023
iOx:
PORT-2 (IMM60)	Melanoma & Lung Cancers	$	10,968	$	36,181
PORT-3 (IMM65)	Ovarian/Prostate Cancers		–		21,709
			10,968		57,890
Oncomer/Saugatuck	DNA Aptamers		178		178
Tarus:
PORT-6 & PORT-7	Adenosine Receptors		22,723		22,723
PORT-8	Adenosine Receptors		420		420
PORT-9	Adenosine Receptors		472		472
			23,615		23,615
In-process research and development		$	34,761	$	81,683
Deferred tax liability		$	1,549	$	13,195